Increasing Incidence of Chronic Conditions is Driving the Global Image-Guided Therapy Systems Market

Published: Aug 2022

The global image-guided therapy systems market is anticipated to grow at a considerable CAGR of 5.4% during the forecast period. The increasing incidences of chronic diseases such as hypertension, high cholesterol, cancer, and others propelled the higher adoption of image-guided therapy systems. For instance, in August 2021, according to World Health Organization (WHO), approximately 1.28 billion adults aged 30-79 years across the globe are living with hypertension and an estimated 1 in 5 adults (21%) with hypertension have it under control and it is a major cause of premature death globally. WHO has also targeted non-communicable diseases to reduce the prevalence of hypertension by 33% between 2010 and 2030.

Browse the full report description of “Image-guided Therapy Systems Market Size, Share & Trends Analysis Report by Product (Endoscopes, Ultrasound Systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and Others), by Application (Neurosurgery, Cardiac Surgery, Urology, Orthopedic Surgery, Oncology Surgery, and Others), and by End-User (Hospitals, Ambulatory Surgery Centers, and Specialty Clinics) and Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/image-guided-therapy-systems-market

Moreover, in 2021, the WHO released a new guideline for the pharmacological treatment of hypertension in adults. This new guideline assists with the evidence-based recommendations for the initiation of treatment of hypertension and recommended intervals for follow-up. The African Region of WHO has the highest prevalence of hypertension (27%) while the WHO egion of America has the lowest prevalence of hypertension that is (18%). It also stated that an estimated 46% of adults with hypertension are unaware of which less than half of adults (42%) with hypertension are diagnosed and treated. Thus due to such factors the image-guided therapy systems market is driven further. 

Market Coverage

The market number available for – 2021-2028

Base year- 2021

Forecast period- 2022-2028

Segment Covered- 

o By Product

o By Application

o By End-User

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- Abbott, Canon Medical Systems Corp., General Electric Co., Koninklijke Philips N.V., Medtronic Plc, Stryker Corp., Zeta Surgical Inc., and others.

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

Who is the leader in the market?

How players are addressing challenges to sustain growth?

Where is the investment opportunity?

Global Image-guided Therapy Systems Market Report Segment

By Product Type

  • Endoscopes
  • Ultrasound Systems
  • Computed Tomography (CT) Scanners
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET)
  • Others (X-ray Fluoroscopy)

By Application

  • Neurosurgery
  • Cardiac Surgery
  • Urology
  • Orthopedic Surgery
  • Oncology Surgery
  • Others (Gastroenterology)

By End-User

  • Hospitals
  • Ambulatory Surgery Centers
  • Speciality Clinics

Global Image-Guided Therapy Systems Market Report by Region

North America

US

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe 

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific 

Rest of the World

Latin America 

Middle East & Africa


To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/image-guided-therapy-systems-market